商業用バイオテクノロジー分離システム市場：方法、用途別-2025～2030年の世界予測

商業用バイオテクノロジー分離システム市場は、2023年に265億5,000万米ドルと評価され、2024年には296億5,000万米ドルに達すると予測され、CAGR 12.14％で成長し、2030年には592億4,000万米ドルになると予測されています。

商業用バイオテクノロジー分離システム市場には、複雑な混合物から生物学的分子、細胞、粒子を分離するために設計された技術とプロセスが含まれ、製薬、研究所、工業用バイオプロセスへの応用が可能です。このセグメントの成長の原動力は、バイオ医薬品に対する需要の増加、ゲノミクスとプロテオミクスの進歩、高純度生物製剤に対するニーズの高まりです。主要技術には、遠心分離、膜濾過、クロマトグラフィー、電気泳動などがあり、創薬、タンパク質回収、細胞培養プロセスなどで幅広く利用されています。バイオテクノロジーの用途は拡大を続けており、医療、農業、環境管理が重要な最終用途として浮上しています。革新的な治療オプションが必要とされる慢性疾患の蔓延が拡大していることと、作物収量向上のための農業におけるバイオテクノロジー・用途の拡大が、極めて重要な成長促進要因となっています。研究開発に対する政府投資の増加は、個別化医療と生物学的療法の採用の拡大と相まって、市場参入企業に有利な機会を提供しています。しかし、初期設定コストの高さ、規制環境の厳しさ、先進的分離システムの取り扱いに伴う技術的な複雑さといった課題が、大きな障壁となっています。それにもかかわらず、この市場は、特にシステム効率の向上、費用対効果の高いソリューションの開拓、分離プロセスの最適化のためのAIの統合において、十分なイノベーションの可能性を示しています。新規の生体適合材料と拡大可能なシステムに焦点を当てた調査は、探求の機が熟しています。競合情勢は、効率性の向上と製品ポートフォリオの拡大を対象とした急速な技術進歩と戦略的提携によって特徴付けられます。企業は技術革新と戦略的提携に注力し、市場での地位を強化すべきです。手頃な価格で柔軟性と信頼性の高いバイオプロセシングシステムを開拓し、規制基準への適合を確保しながらスケーラビリティに対応することで、大きな市場機会を掘り起こすことができます。バイオテクノロジー応用の世界の急増に対応するために、これらの技術を拡大することは、永続的な成長にとって極めて重要であり、規制要件に対する適応的なアプローチは、潜在的な課題を軽減することになります。結局のところ、市場情勢はダイナミックであり、継続的なイノベーションと進化する市場ニーズへの迅速な適応が成長の条件となります。

市場力学：急速に進化する商業用バイオテクノロジー分離システム市場の主要市場洞察を公開

商業用バイオテクノロジー分離システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化医薬品と細胞ベースの治療に対する需要の高まり
  • 政府による研究開発資金の増加
  • プラスチックや化学品の商業生産における磁気分離器の採用拡大
• 市場抑制要因
  • 商業用バイオテクノロジー分離システムに関連する高コスト
• 市場機会
  • 商業用バイオテクノロジー分離システムの継続的進歩
  • 政府が中小企業に新技術導入のための資金援助を提供
• 市場課題
  • 製品品質に対する厳しい規制要件に関する問題

ポーターのファイブフォース：商業用バイオテクノロジー分離システム市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：商業用バイオテクノロジー分離システム市場における外部からの影響の把握

外部マクロ環境要因は、商業用バイオテクノロジー分離システム市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：商業用バイオテクノロジー分離システム市場における競合情勢の把握

商業用バイオテクノロジー分離システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス商業用バイオテクノロジー分離システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、商業用バイオテクノロジー分離システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：商業用バイオテクノロジー分離システム市場における成功への道筋を描く

商業用バイオテクノロジー分離システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズされた医薬品と細胞ベースの治療法に対する需要の高まり
    • 政府による研究開発への資金提供の増加
    • プラスチックと化学品の商業生産における磁気分離機の採用拡大
  • 抑制要因
    • 商業用バイオテクノロジー分離システムに関連する高コスト
  • 機会
    • 商業用バイオテクノロジー分離システムの継続的な進歩
    • 政府は中小企業に新技術導入のための財政支援を提供
  • 課題
    • 製品の品質に対する厳しい規制要件に関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 商業用バイオテクノロジー分離システム市場：方法別

• イントロダクション
• 従来型方法
  • 遠心分離
  • クロマトグラフィー
  • 電気泳動
  • フローサイトメトリー
  • 膜濾過
• 現代型方法
  • バイオチップ
  • ラボオンチップ
  • 磁気分離
  • マイクロアレイ

第7章 商業用バイオテクノロジー分離システム市場：用途別

• イントロダクション
• 農業
• バイオ医薬品
• 化粧品・パーソナルケア
• 飲食品

第8章 南北アメリカの商業用バイオテクノロジー分離システム市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の商業用バイオテクノロジー分離システム市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの商業用バイオテクノロジー分離システム市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Alfa Laval AB
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Danaher Corporation
• GE HealthCare Technologies Inc.
• GL Sciences Inc.
• Hitachi, Ltd.
• Illumina, Inc.
• JASCO International Co., Ltd.
• LECO Corporation
• Luminex Corporation by DiaSorin S.p.A.
• Merck KGaA
• Miltenyi BIoTec B.V. & Co. KG
• Novasep Holding SAS
• PerkinElmer Inc.
• QIAGEN N.V.
• Repligen Corporation
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Tosoh Corporation
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET DYNAMICS
• TABLE 7. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MEMBRANE FILTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY LAB-ON-A-CHIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COSMETICS & PERSONAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 40. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 41. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 62. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 63. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 64. CHINA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 66. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 67. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 68. INDIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 135. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 136. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 137. ITALY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 151. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 152. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 153. POLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 155. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 156. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 157. QATAR COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY CONVENTIONAL METHODS, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY MODERN METHODS, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 195. COMMERCIAL BIOTECHNOLOGY SEPARATION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

The Commercial Biotechnology Separation Systems Market was valued at USD 26.55 billion in 2023, expected to reach USD 29.65 billion in 2024, and is projected to grow at a CAGR of 12.14%, to USD 59.24 billion by 2030.

The commercial biotechnology separation systems market encompasses technologies and processes designed to isolate biological molecules, cells, or particles from complex mixtures, instrumental for applications in pharmaceuticals, research laboratories, and industrial bioprocessing. This sector's growth is driven by an increasing demand for biopharmaceuticals, advancements in genomics and proteomics, and the rising need for high-purity biological products. Key technologies include centrifugation, membrane filtration, chromatography, and electrophoresis, utilized extensively across drug discovery, protein recovery, and cell culture processes. Biotechnological applications continue to expand, with healthcare, agriculture, and environmental management emerging as significant end-uses. The growing prevalence of chronic diseases, necessitating innovative treatment options, alongside expanding biotechnological applications in agriculture for improved crop yield, are pivotal growth drivers. The rise in government investments in research and development, paired with the escalating adoption of personalized medicine and biological therapies, offers favorable opportunities for market players. However, challenges such as high initial setup costs, stringent regulatory environments, and technical complexities associated with handling advanced separation systems pose significant barriers. Nonetheless, this market presents ample innovation potential, particularly in enhancing system efficiencies, developing cost-effective solutions, and integrating AI for optimizing separation processes. Research focused on novel biocompatible materials and scalable systems are ripe for exploration. The competitive landscape is characterized by rapid technological advancements and strategic collaborations targeting increased efficiency and expanded product portfolios. Businesses should focus on technological innovation and strategic partnerships to bolster their market position. Developing affordable, flexible, and reliable bioprocessing systems addressing scalability while ensuring compliance with regulatory standards can unlock substantial market opportunities. Scaling these technologies to meet the global surge in biotechnology applications will be crucial for enduring growth, while an adaptive approach towards regulatory requirements will mitigate potential challenges. Ultimately, the landscape is dynamic, with growth contingent upon continued innovation and responsive adaptation to evolving market needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Commercial Biotechnology Separation Systems Market

The Commercial Biotechnology Separation Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for personalized medicines and cell-based therapies
  • Rise in funding by the government for research and development
  • Expanding adoption of magnetic separators for commercial production of plastics and chemicals
• Market Restraints
  • High cost associated with commercial biotechnology separation systems
• Market Opportunities
  • Ongoing advancements in commercial biotechnology separation systems
  • Government provides financial assistance to SMEs to introduce novel technologies
• Market Challenges
  • Problems regarding stringent regulation requirements for product quality

Porter's Five Forces: A Strategic Tool for Navigating the Commercial Biotechnology Separation Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Commercial Biotechnology Separation Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Commercial Biotechnology Separation Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Commercial Biotechnology Separation Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Commercial Biotechnology Separation Systems Market

A detailed market share analysis in the Commercial Biotechnology Separation Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Commercial Biotechnology Separation Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Commercial Biotechnology Separation Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Commercial Biotechnology Separation Systems Market

A strategic analysis of the Commercial Biotechnology Separation Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Commercial Biotechnology Separation Systems Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, GE HealthCare Technologies Inc., GL Sciences Inc., Hitachi, Ltd., Illumina, Inc., JASCO International Co., Ltd., LECO Corporation, Luminex Corporation by DiaSorin S.p.A., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novasep Holding SAS, PerkinElmer Inc., QIAGEN N.V., Repligen Corporation, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific Inc., Tosoh Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Commercial Biotechnology Separation Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Method, market is studied across Conventional Methods and Modern Methods. The Conventional Methods is further studied across Centrifugation, Chromatography, Electrophoresis, Flow cytometry, and Membrane filtration. The Modern Methods is further studied across Biochip, Lab-on-a-chip, Magnetic separation, and Microarray.
• Based on Application, market is studied across Agriculture, Biopharmaceutical, Cosmetics & Personal Care, and Food & Beverage.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for personalized medicines and cell-based therapies
    • 5.1.1.2. Rise in funding by the government for research and development
    • 5.1.1.3. Expanding adoption of magnetic separators for commercial production of plastics and chemicals
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with commercial biotechnology separation systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in commercial biotechnology separation systems
    • 5.1.3.2. Government provides financial assistance to SMEs to introduce novel technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Problems regarding stringent regulation requirements for product quality
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Commercial Biotechnology Separation Systems Market, by Method

• 6.1. Introduction
• 6.2. Conventional Methods
  • 6.2.1. Centrifugation
  • 6.2.2. Chromatography
  • 6.2.3. Electrophoresis
  • 6.2.4. Flow cytometry
  • 6.2.5. Membrane filtration
• 6.3. Modern Methods
  • 6.3.1. Biochip
  • 6.3.2. Lab-on-a-chip
  • 6.3.3. Magnetic separation
  • 6.3.4. Microarray

7. Commercial Biotechnology Separation Systems Market, by Application

• 7.1. Introduction
• 7.2. Agriculture
• 7.3. Biopharmaceutical
• 7.4. Cosmetics & Personal Care
• 7.5. Food & Beverage

8. Americas Commercial Biotechnology Separation Systems Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Commercial Biotechnology Separation Systems Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Commercial Biotechnology Separation Systems Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alfa Laval AB
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux SA
• 6. Danaher Corporation
• 7. GE HealthCare Technologies Inc.
• 8. GL Sciences Inc.
• 9. Hitachi, Ltd.
• 10. Illumina, Inc.
• 11. JASCO International Co., Ltd.
• 12. LECO Corporation
• 13. Luminex Corporation by DiaSorin S.p.A.
• 14. Merck KGaA
• 15. Miltenyi Biotec B.V. & Co. KG
• 16. Novasep Holding SAS
• 17. PerkinElmer Inc.
• 18. QIAGEN N.V.
• 19. Repligen Corporation
• 20. Sartorius AG
• 21. Shimadzu Corporation
• 22. Thermo Fisher Scientific Inc.
• 23. Tosoh Corporation
• 24. Waters Corporation